Seroprevalence and clinical outcomes of SARS-CoV-2 in paediatric patients with rheumatic disease.

MLA

Walters, Heather M., et al. “Seroprevalence and Clinical Outcomes of SARS-CoV-2 in Paediatric Patients with Rheumatic Disease.” Rheumatology (Oxford, England), vol. 61, no. SI2, June 2022, pp. SI112-SI119. EBSCOhost, https://doi.org/10.1093/rheumatology/keab730.

APA

Walters, H. M., Mian, Z., Thomas, L., Cerise, J., Eberhard, B. A., Pagano, E., Gottlieb, B. S., Steigerwald, K., & Hui-Yuen, J. S. (2022). Seroprevalence and clinical outcomes of SARS-CoV-2 in paediatric patients with rheumatic disease. Rheumatology (Oxford, England), 61(SI2), SI112-SI119. https://doi.org/10.1093/rheumatology/keab730

Chicago

Walters, Heather M, Zanab Mian, Lydia Thomas, Jane Cerise, B Anne Eberhard, Eileen Pagano, Beth S Gottlieb, Katherine Steigerwald, and Joyce S Hui-Yuen. 2022. “Seroprevalence and Clinical Outcomes of SARS-CoV-2 in Paediatric Patients with Rheumatic Disease.” Rheumatology (Oxford, England) 61 (SI2): SI112-SI119. doi:10.1093/rheumatology/keab730.